3SBio Inc. Stock price

Equities

1530

KYG8875G1029

Pharmaceuticals

Market Closed - Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
5.98 HKD +4.18% Intraday chart for 3SBio Inc. +10.13% -20.48%

Financials

Sales 2023 7.82B 1.08B 8.46B Sales 2024 * 8.65B 1.2B 9.36B Capitalization 12.71B 1.76B 13.76B
Net income 2023 1.55B 214M 1.68B Net income 2024 * 1.94B 268M 2.09B EV / Sales 2023 2.1 x
Net Debt 2023 * 800M 111M 866M Net Debt 2024 * 1.76B 243M 1.9B EV / Sales 2024 * 1.67 x
P/E ratio 2023
11 x
P/E ratio 2024 *
7.02 x
Employees 5,311
Yield 2023 *
3.03%
Yield 2024 *
4.15%
Free-Float 73.96%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.18%
1 week+10.13%
Current month+15.67%
1 month+15.44%
3 months-17.74%
6 months-10.75%
Current year-20.48%
More quotes
1 week
5.44
Extreme 5.44
6.15
1 month
4.91
Extreme 4.91
6.15
Current year
4.91
Extreme 4.91
7.52
1 year
4.91
Extreme 4.91
8.39
3 years
4.72
Extreme 4.72
12.30
5 years
4.72
Extreme 4.72
16.42
10 years
4.72
Extreme 4.72
23.25
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 92-12-31
Director of Finance/CFO - 23-07-02
Director/Board Member 54 12-06-10
Members of the board TitleAgeSince
Director/Board Member 63 92-12-31
Chief Executive Officer 61 92-12-31
Director/Board Member 54 12-06-10
More insiders
Date Price Change Volume
24-03-28 5.98 +4.18% 15 865 803
24-03-27 5.74 -3.04% 13,508,380
24-03-26 5.92 -0.84% 13,345,380
24-03-25 5.97 +0.51% 26,197,500
24-03-22 5.94 +9.39% 32,957,220

Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT

More quotes
3SBio Inc. is an investment holding company mainly engaged in the the development, production, marketing and sale of pharmaceutical products. The Company's main products include recombinant human thrombopoietin (rhTPO) products, tumor necrosis factor (TNF)?inhibitor products and recombinant human erythropoietin (rhEPO) products. The products are sold under the name of TPIAO, Yisaipu, EPIAO and SEPO. The Company distributes its products within the domestic market and to overseas markets, including Sri Lanka, Dominican Republic and Thailand. The Company's subsidiaries include Collected Mind Limited, Hongkong Sansheng Medical Limited and Shenyang Sunshine Pharmaceutical Co., Ltd.. Through its subsidiaries, the Company is engaged in project management and consultation.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
5.302 CNY
Average target price
6.944 CNY
Spread / Average Target
+30.96%
Consensus
  1. Stock
  2. Equities
  3. Stock 3SBio Inc. - Hong Kong S.E.